ABSTRACT
Several common genomic loci, involving various immunity-and metabolism-related genes, have been associated with plasma fibrinogen in European Americans (EA). The genetic determinants of fibrinogen in African Americans (AA) are poorly characterized. Using a vascular genecentric array in 23,634 EA and 6,657 African-American (AA) participants from 6 studies comprising the Candidate gene Association Resource (CARe) project, we examined the association of 47,539 common and lower frequency variants with fibrinogen concentration. We identified a rare Pro265Leu variant in FGB (rs6054) associated with lower fibrinogen. Common fibrinogen gene SNPs (FGB rs1800787 and FGG rs2066861) significantly associated with fibrinogen in EAs were prevalent in AA and showed consistent associations. Several fibrinogen locus SNPs associated with lower fibrinogen were exclusive to AA; these include a newly reported association with FGA rs10050257. For IL6R, IL1RN, and NLRP3 inflammatory gene loci, associations with fibrinogen were concordant between EA and AA, but not at other loci (CPS1, PCCB, and SCL22A5-IRF1). The association of FGG rs2066861 with fibrinogen differed according to assay type used to measure fibrinogen. Further characterization of common and lower-frequency genetic variants that contribute to inter-population differences in fibrinogen phenotype may help refine our understanding of the contribution of hemostasis and inflammation to athero-thrombotic risk.
For personal use only. at UNIV NORTH CAROLINA on November 8, 2010 . www.bloodjournal.org From
INTRODUCTION
Fibrinogen plays a central role in hemostasis and is also a marker of inflammation. Increased plasma fibrinogen concentration is a well-established risk factor for cardiovascular disease (CVD) 1 . Recent genome-wide scans have provided strong evidence that common polymorphisms of the fibrinogen structural genes on chromosome 4 (FGA, FGB, and FGG) and several other genomic loci (IL6R, CPS1, PCCB, NLRP3, IL1RN, CD300LF, IRF1-SCL22A5) influence fibrinogen in European-American (EA) populations [2] [3] [4] [5] [6] . Nonetheless, common polymorphisms explain only a small portion of the heritable component of fibrinogen, which has estimates of ~20% to 50% in EAs [7] [8] [9] . Thus, additional genetic variants with more subtle effects, geneenvironment interactions, or lower frequency variants with large effects might account for additional inter-individual variation in fibrinogen.
Fibrinogen levels differ by race/ethnicity, with higher levels among African Americans (AA) than EA [10] [11] [12] [13] [14] . Fibrinogen predicts CVD risk in AA as well as EA 15 . Heterogeneity between EA and AA in the allelic patterns of fibrinogen phenotype association has been noted for the fibrinogen structural genes on chromosome 4 3, 16 . Little is known about other genomic loci that might account for inter-individual differences in fibrinogen between EA and other U.S. minority populations.
The ITMAT-Broad-CARe (IBC) genotyping array is a custom, CVD gene-centric single nucleotide polymorphism (SNP) genotyping platform that contains greater SNP marker density and linkage disequilibrium coverage for over 2000 CVD candidate regions than current genomewide arrays. The IBC array is particularly informative for individuals of African descent, enabling analyses of common and lower frequency variants in diverse populations 17 .
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We analyzed the association between the SNPs on the IBC candidate gene array and fibrinogen levels in a large number of EA and AA participants from 6 population-based cohorts from the Candidate gene Association Resource (CARe) project. Our objectives were (1) to perform a detailed characterization and comparative analysis of the allelic patterns of association for the fibrinogen gene locus and other fibrinogen-associated candidate gene regions in EA and AA; and (2) evaluate whether other common or less frequent variants at these or other candidate gene loci, or gene-environment interaction, explain any of the "missing heritability" of fibrinogen.
Secondarily, we assessed the potential heterogeneity of fibrinogen SNP associations according to the type of assay used to measure fibrinogen (functional versus immunologic).
MATERIALS AND METHODS
The CARe Consortium is a NHLBI supported resource for analyses of the association of genotypes with heart, lung, and blood phenotypes. CARe cohort studies with fibrinogen measurements include the Atherosclerosis Risk in Communities (ARIC) study, the Coronary Artery Risk Development in Young Adults (CARDIA) study, the Cleveland Family Study (CFS), the Cardiovascular Health Study (CHS), the Framingham Heart Study (FHS), and the Multi-Ethnic Study of Atherosclerosis (MESA). All participating institutions and care sites gave institutional review board approval for this study. Further details of the participating CARe studies are given under Supplemental Methods.
Fibrinogen Measurement
In ARIC, CFS, and CHS, the Clauss clotting rate method 18 
RESULTS
The sample size and participant characteristics from each study are shown in Table 1 . Mean fibrinogen levels were higher in AA than EA. A total of 32 SNPs spanning 11 candidate gene regions were significantly associated with fibrinogen in EA (p-value range 10 -6 -10 -39 ,
Supplemental Table 1 and Supplemental Figure 1 ). Results were similar when the analyses were restricted to the approximately 3,867 CARe EA participants from CARDIA, MESA, and CFS, who were not included as part of the CHARGE consortium fibrinogen GWAS (data not shown). In the smaller AA sample, a total of 6 SNPs were significantly associated with fibrinogen (p-value range 10 -6 -10 -11 , Supplemental Table 2 and Supplemental Figure 1 ), all located in the chromosome 4 fibrinogen structural gene region.
Common fibrinogen-associated SNPs in EA
The majority of SNPs significantly associated with fibrinogen in EA were common, with minor allele frequencies >20%. Of the 32 SNPs that reached the threshold of experiment-wide significance, 14 SNPs could be considered to represent potential independent association signals.
SNPs previously associated with fibrinogen in GWAS of EA that are replicated in the current report, and those SNPs newly associated with fibrinogen in the current study, are indicated in Table 2 . Based on assessment of regional linkage disequilibrium patterns and conditional regression analyses in the overall CARe EA sample (n=23,634), there was most likely a single association signal present within each of the IL6R, CPS1, PCCB, and HDLBP genes (tagged by rs7529229, rs7422339, rs3821445, and rs6752050, respectively). In 4 genes, we found evidence of more than one independent fibrinogen-associated SNP. Within NLRP3, the minor allele of rs4925659 associated with higher fibrinogen and the minor allele of rs12239046 associated with lower levels. The minor allele of IL1RN rs315921 was associated with lower fibrinogen levels. Table 2 and Figure 2 ). This LD bin includes rs1016988 and rs2522056, which were previously reported to be associated with circulating fibrinogen 5, 6 . In a conditional regression analysis of this region (adjusting for rs6874639), only rs6873426 remained associated with fibrinogen (p=1.2 x 10 -5 ).
Low frequency fibrinogen-associated variants
Two SNPs with minor allele frequencies of <5% showed evidence of association with fibrinogen in EA ( Table 2) . A low frequency non-synonymous Pro265Leu variant of the fibrinogen betachain encoded by FGB rs6054 (MAF=0.4% in EA and 0.2% in AA) was significantly associated with fibrinogen concentration, even following adjustment for the top common FGB variant rs1800787 (p=1 x 10 -18 ). Haplotype analysis across the FGB region confirmed that the rs6054 rare variant allele likely arose on a common ancestral haplotype (allele frequency ~30% in EA) that is distinct from the 'high-fibrinogen' FGB haplotype tagged by rs1800787. A nonsynonymous coding variant of HNF4A with a MAF of 3% in EA (rs1800961 encoding an Ile139Thr missense substitution) was associated with lower fibrinogen, though it did not reach the threshold of statistical significance (p=5 x 10 -6 ).
Fibrinogen-associated loci in AA and comparison with EA results
The 6 SNPs significantly associated with fibrinogen in the AA sample ( was also no evidence of association for IL1RN rs315921 or HDLBP rs6752050, though the frequencies of the respective minor alleles were considerably lower among AA than EA.
By comparing the SNP phenotype association results between EA and AA, in some instances the regional LD patterns suggested further localization of the putative causal variant(s). These findings are described in further detail under Supplemental Material.
Between-study heterogeneity and gene-environment interaction
In the combined meta-analysis, the FGG SNP cluster tagged by rs2066861 showed strong intercohort differences in association with fibrinogen (p-value for heterogeneity = 1 x 10 -9 ). Table 5 shows the individual study association results for the 3 fibrinogen structural gene region nonredundant SNPs associated with fibrinogen phenotype in EA. While the SNP regression coefficients for rs1800787 and rs6054 are consistent across studies, rs2066861 is strongly associated with lower fibrinogen only in ARIC and CHS, the two largest studies that used the Clauss functional fibrinogen assay. By testing several study characteristics and summary measures, the type of fibrinogen assay explained almost all (96.3%) of the between-study variance associated with rs2066861 in FGG. Similar between-cohort differences for rs2066861
were observed among the AA cohorts (p-value for heterogeneity = 7 x 10 -5 ). Within FHS, there was no evidence for heterogeneity of results between the parent, offspring, and generation 3
cohorts. There was no significant interaction between the significant SNPs and sex, current smoking, or obesity in either European Americans or African-Americans (data not shown).
DISCUSSION
In this large population-based study, we were able to simultaneously confirm and more precisely characterize the genetic variants associated with fibrinogen in EA 5, 6 and also compare and contrast results of the association findings within an under-represented minority population of AA. In EA, we identified multiple SNPs independently associated with fibrinogen at FGB-FGA-FGG, NLRP3, IL1RN, and IRF1-SCL22A5. We note concordance of EA and AA fibrinogen association results at two common fibrinogen loci (FGB rs1800787 and FGG rs2066861), as well as at several additional loci within inflammatory genes (IL6R, IL1RN, NLRP3) for which there is strong prior evidence of association with fibrinogen based on EA GWAS or CARe IBC results. We also identified a new low frequency non-synonymous FGB variant (rs6054 encoding β-fibrinogen Pro265Leu) associated with lower fibrinogen levels.
The current study includes by far the largest AA sample (n=6,657) evaluated for genetic factors associated with plasma fibrinogen. Our results confirm the association of several SNPs (rs2066874, rs2070017, and rs6058) previously identified through candidate gene analyses in single cohort studies of CARDIA and CHS AAs. 3, 16 We also report a novel association with rs10050257, located ~5kb upstream of the FGA transcription start site. We used a genotyping array that has denser linkage disequilibrium and broader population coverage of previously identified candidate gene regions for AA than current GWAS platforms. Currently, our ability to perform replicate the novel rs10050257 association is limited by (a) the unavailability of additional African-American samples genotyped using the IBC genotyping array; (b) the relatively low allele frequency of these African-American SNPs, which are not present on current GWAS genotyping platforms.
For
org From
While some loci were consistently associated with fibrinogen between EA and AA, others were not. Several fibrinogen-associated SNPs in FGA, FGB, and FGG were exclusive to AAs. Other loci were associated with fibrinogen phenotype only among EA. The latter could possibly be due to the smaller AA size as compared to the EA sample or to different LD patterns between these populations. Based on population-specific effect sizes and/or allele frequency differences, it is possible that some of these loci might account in part for the higher fibrinogen levels in AA compared to EA.
Despite the consistent heritability of fibrinogen [7] [8] [9] , none of the previously or newly identified significant SNPs in our study explain a large portion of the variation in fibrinogen. Together, the common and low frequency SNPs explained 2.2%-15% of the variation in circulating fibrinogen among EA cohorts and 1.8%-3.8% among AA cohorts. For the newly identified lower frequency variants, the percent explained by rs6054 and rs1800961 together ranged from 0.3%-1.0%. We also found no evidence that gene by environment interactions are important in determining fibrinogen levels in either racial/ethnic group, though the number of environmental factors examined was limited. promoter is required to confirm the mechanism of association for rs10050257.
While evidence for association of common FGA, FGB, and FGG variants with thrombotic risk has been inconsistent, [25] [26] [27] [28] [29] familial dysfibrinogenemias due to rare fibrinogen gene mutations have been associated with either thrombosis or hemorrhage. 30 Mutations in the fibrinogen genes leading to amyloidosis have also been described 31 ; and recent evidence suggests that fibrinogen may be involved in the pathogenesis of Alzheimer's disease 32 . The β-fibrinogen Pro265Leu polymorphism (rs6054) is located within an evolutionarily conserved intra-chain disulfide loop that appears to affect fibrinogen secretion and assembly 33 ; this SNP is predicted to alter 'normal' function. 34 The role of the rare Pro265Leu variant in clinical athero-thrombotic disease remains to be determined.
For personal use only. at UNIV NORTH CAROLINA on November 8, 2010. www.bloodjournal.org From Altered splicing regulation may be another mechanism by which fibrinogen gene variants contribute to phenotypic differences in fibrinogen. Both rs6054 and rs6058 (a synonymous SNP located near the splice site of exon 6 of FGB) are predicted to alter splicing enhancer elements. 34 SNPs rs2066861 and rs2066865 (FGG 10034C>T) tag a common FGG haplotype and are located in a region of alternative pre-mRNA processing that results in the formation of the fibrinogen gamma chain isoform, fibrinogen γ ' that appears to be protective against deep vein thrombosis (DVT) 35 . FGG 10034C>T results in a decrease in the ratio of fibrinogen γ ' to γ A and therefore increases risk of DVT 36 and possibly stroke 29 . These FGG SNPs are also in linkage disequilibrium with the Thr312Ala polymorphism (rs6050) of FGA, which is located within the αC domain of fibrinogen, and is important for lateral aggregation and factor XIII-induced crosslinking of fibrin. The Ala312 fibrinogen-α chain variant has been associated with venous thrombosis 37 or post-stroke mortality in subjects with atrial fibrillation. 38 The Ala312 variant has also been associated with altered clot structure, and therefore may predispose to clot embolization. 39 Fibrinogen can be measured using either a functional Clauss method or an antigen method. In most individuals, the results of the two assays are highly correlated, but discrepancies can occur since the immunoassay and functional assay measure different properties of fibrinogen 40, 41 . In the current study, we tested for between-study differences in genotype-fibrinogen association results according to type of fibrinogen assay at the stage of meta-analysis. The use of the fibrinogen immunoassay in two of the six CARe studies allowed us to confirm that the common Crohn's disease susceptibility 46 . The protein encoded by CPS1 is an enzyme that catalyzes the initial step of the hepatic urea cycle. The non-synonymous CPS1 variant rs7422339 (Thr1405Asn) has been associated with vascular and inflammatory disease 47 , and was recently associated with homocysteine 48 .
Several other fibrinogen phenotype-associated genes have functional associations with lipid metabolism, another important determinant of vascular risk. A variant of PCCB, which encodes the beta subunit of the amino acid catabolic enzyme propionyl-CoA carboxylase, was recently associated with small HDL particle concentration 49 . Previous studies have consistently found that HDL cholesterol is inversely associated with fibrinogen 50 . High density lipoprotein-binding protein (HDLBP) may function in the removal of excess cellular cholesterol and has been colocalized with apolipoprotein E in cholesterol-loaded plaque macrophages 51 . The Thr130Ile variant of HNF4A (rs1800961) is located in the DNA binding domain of the transcription factor HNF-4, and has been associated with decreased transcriptional activity in vitro, increased risk of T2D 52 and lower HDL cholesterol levels 53 .
In summary, both common and less frequent sequence variants of inflammatory and hemostatic genes are associated with fibrinogen. It appears that at least some loci contributing to fibrinogen levels differ between AA and EA. Additional studies are needed to better understand the relative contribution of genetic and environmental factors to the chronic systemic inflammatory burden that may underlie inter-population differences in fibrinogen and potentially contribute to CVD risk.
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